Nasdaq plans to delist BNB treasury company Windtree Therapeutics for violations
2025-08-20 22:57:59
Nasdaq plans to delist BNB treasury company Windtree Therapeutics (ticker: WINT) after failing to comply with Nasdaq Listing Rule 5550 (a) (2), which requires minimum bids for shares to remain above $1. Windtree confirmed its non-compliance in a filing with the Securities Supervision Commission.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
纳斯达克因违规拟摘牌BNB财库公司Windtree TherapeuticsNext article：
金色晨讯 | 8月21日隔夜重要动态一览
